Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo
Open Access
- 1 December 2001
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (24) , 1840-1846
- https://doi.org/10.1038/sj.gt.3301597
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The restenosis paradigm revisited: An alternative proposal for cellular mechanismsPublished by Elsevier ,2010
- Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancerCancer Gene Therapy, 2000
- Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovirCancer Gene Therapy, 2000
- Inhibition of Rat Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Recombinant Replication-Competent Herpes Simplex VirusStroke, 1999
- Local Adenovirus-Mediated Delivery of Hirudin in a Rabbit Arterial Injury ModelJournal of Vascular Research, 1999
- Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumorsGene Therapy, 1998
- Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injuryJournal of Vascular Surgery, 1997
- High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid–DNA complexGene Therapy, 1997
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in CultureScience, 1990